Literature DB >> 7108541

Estimation of the turnover of 3-methoxytyramine in the rat striatum by HPLC with electrochemical detection: implications for the sequence in the cerebral metabolism of dopamine.

B H Westerink, S J Spaan.   

Abstract

A highly sensitive method for the determination of 3-methoxytyramine (3-MT) in nervous tissue is described. The method is based on a rapidly performed isolation of 3-MT on small columns of Sephadex G 10, followed by reverse-phase high-performance liquid chromatography in conjunction with a rotating disk electrochemical detector. The detection limit of the assay (0.5-1 pmol/tissue sample) is about 10% of control value for microwave-killed rats. 3-MT as well as dopamine could be quantified in the same chromatographic run. Inhibition of catechol-O-methyl transferase with tropolone resulted in an exponential decline of 3-MT. From this exponential decline a turnover rate for 3-MT of 1.9 nmol/gh/h was calculated. In the same group of rats the turnover rate of homovanillic acid was 9.1 nmol/g/h. From these data it is concluded that in the rat striatum about 80% of homovanillic acid is formed from 3,4-dihydroxyphenylacetic acid and 20% from 3-MT.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7108541     DOI: 10.1111/j.1471-4159.1982.tb08634.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.

Authors:  C A Altar; W C Boyar; A Wasley; S C Gerhardt; J M Liebman; P L Wood
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

2.  Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: I. Levels of dopamine and metabolites.

Authors:  Z J Yu; D K Lim; B Hoskins; R W Rockhold; I K Ho
Journal:  Neurochem Res       Date:  1990-06       Impact factor: 3.996

3.  Chronic nicotine treatment changes differentially the effects of acute nicotine on the three main dopamine metabolites in mouse striatum.

Authors:  T Leikola-Pelho; J Heinämäki; I Laakso; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

4.  The involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatment.

Authors:  J Airio; L Ahtee
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

5.  Withdrawal from repeated morphine sensitizes mice to the striatal dopamine release enhancing effect of acute morphine.

Authors:  J Airio; M Attila; T Leikola-Pelho; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

6.  The dopamine metabolite 3-methoxytyramine is a neuromodulator.

Authors:  Tatyana D Sotnikova; Jean-Martin Beaulieu; Stefano Espinoza; Bernard Masri; Xiaodong Zhang; Ali Salahpour; Larry S Barak; Marc G Caron; Raul R Gainetdinov
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

7.  A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity.

Authors:  M G Feenstra; C Sumners; J H Goedemoed; J B de Vries; H Rollema; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

8.  Probenecid sensitive pathway of elimination of dopamine and serotonin metabolites in CSF of the rat.

Authors:  J L Elghozi; E Mignot; K H Le Quan-Bui
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

9.  Modification of dopamine and norepinephrine metabolism in the rat brain by monoamine oxidase inhibitors.

Authors:  N T Buu; M Angers; J Duhaime; O Kuchel
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

10.  gamma-Glutamyl conjugation of 5-hydroxytryptamine (serotonin) in the earthworm (Lumbricus terrestris).

Authors:  B D Sloley
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.